Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling
about
Cerebral Cavernous Malformations: Review of the Genetic and Protein-Protein Interactions Resulting in Disease PathogenesisRHO binding to FAM65A regulates Golgi reorientation during cell migrationRhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix.Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex.Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke.Expression of CCM2 and CCM3 during mouse gonadogenesisThe cerebral cavernous malformation proteins CCM2L and CCM2 prevent the activation of the MAP kinase MEKK3.Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.Rho-kinase: regulation, (dys)function, and inhibition.CCM1 and the second life of proteins in adhesion complexes.B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations
P2860
Q28072671-261614B1-A29E-4EF0-9F60-0218B60340C5Q29147496-FB6C1812-01CF-4CF4-9818-4878C39E8CCAQ30276897-451CF337-88FC-44EC-8AA9-D0D591BB085EQ34315697-5358BE3F-4060-4A0B-8A9E-4C7D47F0AE02Q35919937-23108A1B-EFF5-4D99-BB8A-FF86A8C37766Q35961406-F720B4CC-5AF7-406F-8652-8295E756092CQ36192108-F3B5EA28-3574-474C-9584-F2693869CFADQ36306059-80DA7506-3491-4990-8A54-FE83DD545D00Q37050968-26FDF0CD-E336-4E7A-B02D-79749C83A8EFQ37722299-69DD429C-861E-477F-8790-4A72B51C95B8Q38129373-E88C77C8-64BB-46D6-AD76-EDF330DCEC50Q38203137-9FA29D30-ED6F-4627-95EB-59F47DF3E631Q38880171-545D4C54-ACCB-49AF-AED7-466E599B63B1Q38957623-BF747631-503B-42E0-9A40-129AA703BCBAQ58764066-75ECF7ED-A692-49FD-95F8-2D32D59E1210
P2860
Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cerebral cavernous malformatio ...... with activated RhoA signaling
@ast
Cerebral cavernous malformatio ...... with activated RhoA signaling
@en
Cerebral cavernous malformatio ...... with activated RhoA signaling
@nl
type
label
Cerebral cavernous malformatio ...... with activated RhoA signaling
@ast
Cerebral cavernous malformatio ...... with activated RhoA signaling
@en
Cerebral cavernous malformatio ...... with activated RhoA signaling
@nl
prefLabel
Cerebral cavernous malformatio ...... with activated RhoA signaling
@ast
Cerebral cavernous malformatio ...... with activated RhoA signaling
@en
Cerebral cavernous malformatio ...... with activated RhoA signaling
@nl
P2093
P2860
P3181
P356
P1433
P1476
Cerebral cavernous malformatio ...... with activated RhoA signaling
@en
P2093
Asya L. Borikova
Bryan T. Richardson
Christopher F. Dibble
Gary L. Johnson
P2860
P3181
P356
10.1515/HSZ-2012-0243
P407
P577
2013-01-01T00:00:00Z